Filing Details

Accession Number:
0001193125-26-046663
Form Type:
4
Zero Holdings:
No
Publication Time:
2026-02-11 16:30:06
Reporting Period:
2026-02-09
Filing Date:
2026-02-11
Accepted Time:
2026-02-11 16:30:06
SEC Url:
Form 4 Filing
10b5-1 trading plan:
Unchecked
Issuer
Cik Name Symbol Sector (SIC) IRS No
1778922 Spyglass Pharma Inc. SGP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746342 Carmen Chang 2855 Sand Hill Road
Menlo Park CA 94025
No No No No
Transaction Summary
Purchased: 937,500 shares Avg. Price: $16.00 Total Value: $15,000,000.00
Number of Shares After Transactions: 1,357,263 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2026-02-09 1,619,240 Not reported 1,619,240 No 4 C Indirect See Note 2
Common Stock Acquisiton 2026-02-09 1,370,168 Not reported 2,989,408 No 4 C Indirect See Note 2
Common Stock Acquisiton 2026-02-09 1,370,168 Not reported 4,359,576 No 4 C Indirect See Note 2
Common Stock Acquisiton 2026-02-09 737,962 Not reported 5,097,538 No 4 C Indirect See Note 2
Common Stock Acquisiton 2026-02-09 937,500 $16.00 6,035,038 No 4 P Indirect See Note 2
Common Stock Acquisiton 2026-02-09 954,990 Not reported 954,990 No 4 C Indirect See Note 3
Common Stock Acquisiton 2026-02-09 402,273 Not reported 1,357,263 No 4 C Indirect See Note 3
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 C Indirect See Note 2
No 4 P Indirect See Note 2
No 4 C Indirect See Note 3
No 4 C Indirect See Note 3
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2026-02-09 1,619,240 $0.00 1,619,240 $0.00
Common Stock Series C-1 Preferred Stock Disposition 2026-02-09 1,370,168 $0.00 1,370,168 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2026-02-09 1,370,168 $0.00 1,370,168 $0.00
Common Stock Series D Preferred Stock Disposition 2026-02-09 737,962 $0.00 737,962 $0.00
Common Stock Series A Preferred Stock Disposition 2026-02-09 954,990 $0.00 954,990 $0.00
Common Stock Series B Preferred Stock Disposition 2026-02-09 402,273 $0.00 402,273 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. All shares of the preferred stock, par value $0.00001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), prior to the closing of the Issuer's initial public offering of its Common Stock on February 9, 2026.
  2. The Reporting Person is a manager of NEA 17 GP, LLC, which is the sole general partner of NEA Partners 17, L.P. ("NEA Partners 17"). NEA Partners 17 is the sole general partner of New Enterprise Associates 17, L.P. ("NEA 17"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise of such portion of the securities held by NEA 17 in which the Reporting Person has no pecuniary interest.
  3. The Reporting Person is a manager of NEA 16 GP, LLC, which is the sole general partner of NEA Partners 16, L.P. ("NEA Partners 16"). NEA Partners 16 is the sole general partner of New Enterprise Associates 16, L.P. ("NEA 16"), the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Exchange Act or otherwise of such portion of the securities held by NEA 16 in which the Reporting Person has no pecuniary interest.